This further suggests a dose dependent effect of Gata2a in hematopoietic cells may drive the leukemic phenotype, or the acquisition of second hit mutations that drive the formation of leukemia’s in GATA2 deficiency. The gene discussed is GATA2; the disease is leukemia.